
Derma Face Pharmaceuticals LLP
About Derma Face Pharmaceuticals LLP
Data last updated:
Derma Face Pharmaceuticals LLP is a limited liability partnership (LLP) based in Navi Mumbai, Maharashtra, India. It operates in the research and development sector. It was incorporated on 03 January 2023.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ABZ-7298.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Arvindkumar Harinarayan Shukla and Ajit Bajirao Patil.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at H No – 2285/001 Chandrageet Building, Nr Sadguru Socity Arjun Wadi Ghansoli Navi Mumbai, Maharashtra, India – 400701.
Company details
Contact details
Derma Face Pharmaceuticals LLP's registered office is in Navi Mumbai, Maharashtra.
- Registered AddressH No – 2285/001 Chandrageet Building, Nr Sadguru Socity Arjun Wadi Ghansoli Navi Mumbai, Maharashtra, India – 400701
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Derma Face Pharmaceuticals LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ||
| Other Income | ||
| Total Income | ||
| Purchases and Direct Costs | ||
| Personnel Expenses | ||
| Administrative Expenses | ||
| Interest | ||
| Depreciation | ||
| Total Expenses | ||
| Profit Before Tax | ||
| Tax | ||
| Profit After Tax | ||
| Profit Transferred to Partners | ||
| Assets and Liabilities | ||
| Partners' Contribution | ||
| Reserves and Surplus | ||
| Secured Loans | ||
| Unsecured Loans | ||
| Trade Payables | ||
| Other Liabilities and Provisions | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Loans and Advances | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | ||
| Return on Partners' Funds | ||
| Return on Assets | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Debt to Partners' Funds | ||
| Interest Coverage | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Turnover Growth | ||
| Profit Growth | ||
To see the full financial statements and ratios of Derma Face Pharmaceuticals LLP, buy the company report.
Designated partners of Derma Face Pharmaceuticals LLP
Derma Face Pharmaceuticals has 4 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvindkumar Harinarayan Shukla | Designated Partner | 03 Jan 2023 | 3 Years 10 Months | Current |
| Ajit Bajirao Patil | Designated Partner | 03 Jan 2023 | 3 Years 10 Months | Current |
| Rakesh Sarathlal Saroj | Designated Partner | 03 Jan 2023 | 3 Years 10 Months | Current |
| Sanjay Rajaram Dhanawade | Designated Partner | 03 Jan 2023 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Derma Face Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Derma Face Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Derma Face Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Derma Face Pharmaceuticals LLP has 4 designated partner changes on record since 2023: 4 appointments. The latest: Ajit Bajirao Patil was appointed as Designated Partner on 03 Jan 2023.
Frequently asked questions
Derma Face Pharmaceuticals is an active limited liability partnership based in Navi Mumbai, Maharashtra, India. The LLP works in the research and development industry. It was incorporated on 03 January 2023 (3+ years old) and is registered under LLPIN ABZ-7298.
Derma Face Pharmaceuticals has 4 current designated partners:
- Arvindkumar Harinarayan Shukla - Designated Partner
- Ajit Bajirao Patil - Designated Partner
- Rakesh Sarathlal Saroj - Designated Partner
- Sanjay Rajaram Dhanawade - Designated Partner
The latest financial statements of Derma Face Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2023 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Derma Face Pharmaceuticals is ABZ-7298. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Derma Face Pharmaceuticals was incorporated on 03 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Ajit Bajirao Patil was appointed as Designated Partner on 03 Jan 2023. Arvindkumar Harinarayan Shukla was appointed as Designated Partner on 03 Jan 2023. Rakesh Sarathlal Saroj was appointed as Designated Partner on 03 Jan 2023. Derma Face Pharmaceuticals has 4 designated partner changes on record in total.
The registered office of Derma Face Pharmaceuticals is at H No – 2285001 Chandrageet Building, Nr Sadguru Socity Arjun Wadi Ghansoli Navi Mumbai, Maharashtra, India – 400701.
Derma Face Pharmaceuticals operates in the research and development industry.
Derma Face Pharmaceuticals can be reached at its registered office: H No – 2285001 Chandrageet Building, Nr Sadguru Socity Arjun Wadi Ghansoli Navi Mumbai, Maharashtra, India – 400701.
Derma Face Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

